Position in CRDF
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$62,217
-$173,345 QoQ
Shares Held
38,406
-54.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. CRDF ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CRDF
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,217 | 38,406 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $235,562 | 83,830 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $120,548 | 58,519 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $145,337 | 46,139 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $132,646 | 42,244 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $139,157 | 32,064 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $61,978 | 23,213 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $51,102 | 23,019 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $41,785 | 7,825 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $11,573 | 7,820 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $10,846 | 7,803 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,464 | 7,799 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $12,848 | 7,787 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,356 | 1,683 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,568 | 1,668 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,718 | 1,690 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $23,088 | 9,310 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $127,105 | 21,149 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,846 | 2,980 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,084 | 915 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $55,263 | 5,968 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $757,738 | 42,120 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,336 | 517 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $345 | 69 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||